显著增加CA 19-9的一个非常罕见的原因:类似葡萄糖-1受体激活剂
Rongyue Liang1, Zhifang Fu1, Long Chen1
1Department of Geriatrics, Peking University First Hospital, Beijing, China.
类似葡萄糖类-1受体激动剂 (GLP1-RAs) 可以在2型糖尿病患者中提高癌症抗原19-9 (CA 19-9) 水平. 在停止GLP1-RA后,这种升高会消失,这表明非瘤原因.
科学领域:
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
- 胃肠病学 胃肠病学
背景情况:
- 类似葡萄糖-1受体激动剂 (GLP1-RAs) 是广泛用于治疗2型糖尿病 (T2DM).
- 对GLP1-RAs的不良反应虽然不常见,但需要进行持续调查.
- 瘤标志物升高可能会使癌症诊断和患者管理复杂化.
更多相关视频
07:05Important Endpoints and Proliferative Markers to Assess Small Intestinal Injury and Adaptation using a Mouse Model of Chemotherapy-Induced Mucositis
Published on: May 12, 2019
07:44Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
相关概念视频
Glucagon-like Receptor Agonists
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
Hypoglycemia and Glucagon
Chronic Pancreatitis II: Collaborative Care
Assessment:
Acute Pancreatitis II: Clinical Manifestations and Management
GPCRs Regulate Adenylyl Cylase Activity
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
